KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
|Smart Today=Kim Se-hyung Reporter| The KOSPI is on a roll. It has risen for three consecutive trading days in the year...
Search results for "The H"
BTS 5th Album Release Announcement.."Filled with the Most BTS-like Music"
|Smart Today=Reporter Kim Se-hyung| HYBE officially announced the release of BTS's 5th studio album.
Stock Market Receives the Energy of the Red Horse.. First Day Breaks 4300 for the First Time
|Smart Today=Kim Se-hyung Reporter| The stock market has truly received the energy of the Red Horse in 2026.
KB Financial and the Ministry of Health and Welfare Launch ‘Night Extended Care Project’ for Children Aged 6 to 12 Until Midnight
KB Financial Group (Chairman Yang Jong-hee) announced on the 28th that the ‘Night Extended Care Project’ being promoted...
Choi Young-woo, CEO of SOOP, "Pushing for Platform Integration, AI Advancement, and Strengthening Content Partnerships in the New Year"
|Smart Today=Reporter Kim Se-hyung| SOOP announced its business direction and key plans for 2026 at the '2025 Streamer...
SOOP, Change is Urgent.. Stock Price Expected to Hover for the Time Being - Hanwha Investment
|Smart Today=Reporter Kim Se-hyung| Hanwha Investment & Securities stated on the 22nd that SOOP urgently needs change...
Samba Signs 1.1 Trillion Won Pharmaceutical Production Contract with European Pharmaceutical Company.. Acquisition of Local Production Plant in the U.S.
|Smart Today=Reporter Kim Se-hyung| Samsung Biologics announced on the 22nd that it signed a contract for consignment...
Games, Benefiting from King Dollar.. W Games to See the Largest Benefit - Hana
|Smart Today=Reporter Kim Se-hyung| Hana Securities stated on the 22nd that game companies with a high proportion of...
Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin
|Smart Today=Reporter Kim Se-hyung| Dong-A Pharmaceutical (CEO Baek Sang-hwan) announced on the 27th that it has...
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Biologics achieved an annual revenue of 4.5 trillion won in 2025. It is evaluated that the company has...
Most Viewed
1
Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin
2Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
3Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split
4Samsung Electronics Reports 20 Trillion Won Operating Profit in Q4, Exceeding Heightened Expectations
5KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
Picks for You
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split
KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
Stock Market Receives the Energy of the Red Horse.. First Day Breaks 4300 for the First Time
Samba Signs 1.1 Trillion Won Pharmaceutical Production Contract with European Pharmaceutical Company.. Acquisition of Local Production Plant in the U.S.
Youngpoong·MBK Partners "Korea Zinc, Choi Yoon-bum Takes on High Risks to Secure Management Rights"
Photos & Videos
Lee Chan-won, Model for Dong-A Pharmaceutical's Cold Medicine Panpyrin
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, Target Price of 200,000 Won Emerges.. Equivalent to 10 Million Won Before Stock Split
Samsung Electronics Reports 20 Trillion Won Operating Profit in Q4, Exceeding Heightened Expectations
powered by 